Low glutathione levels are associated with: Faster biological aging Increased oxidative stress and inflammation Neurodegenerative and psychiatric conditions (e.g., Parkinsons disease, Autism Spectrum Disorder, bipolar disorder, major depression, schizophrenia) Greater susceptibility to toxic exposures Higher risk of chronic metabolic and cardiovascular issues in some populations For people focused on high performance and long-term health, keeping glutathione levels supported is a smart target
This margin of safety provides reassurance, though caution remains appropriate given the limited formal human studies
Weight Loss: The Default Job The pivotal obesity trial enrolled about 1,960 non-diabetic adults with a mean weight of 105 kg, BMI of 38, average age of 46, and a cohort that was roughly three-quarters women
Subsequently, beneficial effects of FOXO4-DRI have been demonstrated in various age-related models 6,7,8